Yanagishita M, Hascall V C
J Biol Chem. 1984 Aug 25;259(16):10270-83.
The metabolism of endogenously labeled proteoglycans was studied in rat ovarian granulosa cell cultures by a series of pulse-chase experiments using [35S]sulfate as a precursor. More than 90% of the newly synthesized proteoglycans are transported to the cell surface (trypsin-accessible compartment) with a median transit time of 13 min. The membrane-bound heparan sulfate-proteoglycan (HS-PG) is lost from the cell surface either by release into the medium (30%, with t1/2 of 4 h) or by internalization (70%, with t1/2 of 4 h). Internalized HS-PG, which does not recycle to the cell surface, is degraded by two major pathways. In pathway 1, 60% of the internalized HS-PG migrates to lysosomes with a relatively short t1/2 of 30 min, where it is rapidly degraded, releasing free [35S]sulfate without detectable intermediate products. Chloroquine treatment inhibited degradation, resulting in the accumulation of intact proteoglycans inside the cell. In pathway 2, 40% of the internalized HS-PG is first subjected to extensive proteolysis and limited endoglycosidic degradation yielding single HS chains about 1/3 of their original size (t1/2 of 30 min). Chloroquine did not inhibit this step. The partially degraded HS is then degraded further by limited endoglycosidic activity to about 1/4-1/5 the original size (t1/2 of 30-60 min). This step is inhibited by chloroquine. These smaller fragments have a relatively long t1/2 of 3-4 h before rapid degradation in the lysosomes, releasing free [35S]sulfate. Approximately 7% of the newly synthesized HS-PG that is not transported to the cell surface is degraded directly by pathway 2. The larger dermatan sulfate proteoglycan (DS-I) is transported to the cell surface from which it is quantitatively released into the medium with a t1/2 of 4-6 h. The smaller DS-PG (DS-II) is metabolized similarly to the HS-PG. Most (greater than 90%) is transported to the cell surface from which it is lost either by release into the medium (40%) or by internalization (60%). About 60% of the internalized DS-II is degraded by pathway 1 (t1/2 of 30 min), while the remainder appears to be degraded by pathway 2 with an overall t1/2 of 4 h. However, in contrast to the degradation of HS-PG by pathway 2, no endoglycosidic degradation of the DS chains occurred.
通过一系列以[35S]硫酸盐为前体的脉冲追踪实验,在大鼠卵巢颗粒细胞培养物中研究了内源性标记蛋白聚糖的代谢。超过90%新合成的蛋白聚糖被转运到细胞表面(胰蛋白酶可及区室),中位转运时间为13分钟。膜结合硫酸乙酰肝素蛋白聚糖(HS-PG)从细胞表面丢失的方式有两种,一是释放到培养基中(30%,半衰期为4小时),二是内化(70%,半衰期为4小时)。内化的HS-PG不会再循环到细胞表面,而是通过两条主要途径降解。在途径1中,60%内化的HS-PG以相对较短的30分钟半衰期迁移到溶酶体,在那里迅速降解,释放出游离的[35S]硫酸盐,没有可检测到的中间产物。氯喹处理抑制了降解,导致完整的蛋白聚糖在细胞内积累。在途径2中,40%内化的HS-PG首先经历广泛的蛋白水解和有限的内切糖苷酶降解,产生约为其原始大小1/3的单个HS链(半衰期为30分钟)。氯喹不抑制这一步骤。然后,部分降解的HS通过有限的内切糖苷酶活性进一步降解至约为原始大小的1/4 - 1/5(半衰期为30 - 60分钟)。这一步骤被氯喹抑制。这些较小的片段在溶酶体中快速降解之前有相对较长的3 - 4小时半衰期,释放出游离的[35S]硫酸盐。约7%未转运到细胞表面的新合成HS-PG直接通过途径2降解。较大的硫酸皮肤素蛋白聚糖(DS-I)被转运到细胞表面,然后以4 - 6小时的半衰期定量释放到培养基中。较小的DS-PG(DS-II)的代谢与HS-PG相似。大多数(超过90%)被转运到细胞表面,然后通过释放到培养基中(40%)或内化(60%)而丢失。约60%内化的DS-II通过途径1降解(半衰期为30分钟),而其余部分似乎通过途径2降解,总半衰期为4小时。然而,与途径2中HS-PG的降解不同,DS链没有发生内切糖苷酶降解。